StockData
Grace Therapeutics, Inc. logo

Grace Therapeutics, Inc. (GRCE) income statement

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.71−0.02 (-1.16%)

Close on Nov 20, 2026Market cap $35.97MP/E –Yield –

See a number that looks wrong?